Search results
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 7 hours agoOther times, some corporations lag the market for good reasons: Their businesses and prospects look...
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks via Yahoo Finance· 2 hours agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
The path to a better tuberculosis vaccine runs through Montana
Medical Xpress· 2 hours agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
Novavax, Inc. (NVAX) vs. Its Peers: A Comparison – News Heater
NewsHeater· 6 days agoThere are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.” The public float for NVAX is 132.98M ...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
InvestorPlace· 4 days agoIf you have a high tolerance for volatility then the biotech sector might be for you. Biotech stocks...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 5 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 6 days agoData gathered from over 4 million children revealed that myocarditis or pericarditis occurred at...
Europe Strengthens Future Disease Defense
Medscape· 4 days agoA network of health security agencies has been established in Europe and Central Asia to bolster the region's preparedness to meet future disease...